British Oncology Pharmacy Association

Promoting excellence in the pharmaceutical care of patients with cancer through education, communication, research and innovation.



BOPA Digital Committee

By Netty Cracknell on 17th October 2018

The BOPA digital committee are looking for members. The primary purpose of the group is to promote excellence in the pharmaceutical care of patients by supporting the membership by digital support and increased communication streams. 

Our new BOPA Fellow - Ally McMurray

By Steve Williamson on 16th October 2018

The BOPA committee is proud to announce that our newest BOPA Fellow is Alastair (Ally) McMurray who ‘has long been a role model for oncology pharmacists and pharmacy technicians, both locally and internationally'. 

Fellowship of the British Oncology Pharmacy Association is conferred on the recommendation of the Executive Committee (following a nomination or consultation process that includes membership) in recognition of an outstanding contribution to the work of BOPA and/or supporting oncology pharmacy in its widest sense’

Thank You From BOPA committee

By Steve Williamson on 16th October 2018

The BOPA committee just wants to say thank you to everyone who was with us in birmingham this weekend for helping making #BOPA18 an amazing success. Hope you enjoyed it as much as we did.

National Treatment Record Launch

By Steve Williamson on 16th October 2018

BOPA was delighted to have members of the UK Chemotherapy Board present the new National Treatment Record on sunday.   The presenters were asked if they could share their slides so BOPA members could share the booklet with their local teams please see for summary slides which show the booklet.  Special thanks to Simon Purcell exe BOPA committee member for all the work he has done leading on this project for BOPA.

Update: Capecitabine Warnings from NHS England

By Steve Williamson on 5th October 2018

Both Macmillan (regimen patient information sheets) and CRUK (regimen specific consent forms) are updating their capecitabine containing documents to reference the warnings on Toxic Epidermal Necrolysis (TEN) and Stevens Johnson Syndrome(SJS).